Birth cohort screening may help find hepatitis C cases

JAMA. 2012 Mar 28;307(12):1242. doi: 10.1001/jama.2012.337.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use
  • Cost-Benefit Analysis
  • Health Care Costs
  • Hepatitis C / diagnosis*
  • Hepatitis C / drug therapy
  • Hepatitis C / epidemiology*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Mass Screening / economics*
  • Middle Aged
  • Nutrition Surveys
  • Polyethylene Glycols / therapeutic use
  • Population Growth
  • Prevalence
  • Quality-Adjusted Life Years
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • United States / epidemiology

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b